Effects of storage time and leucocyte burden of packed and buffy-coat depleted red blood cell units on red cell storage lesion. 2010

Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

BACKGROUND The red cell storage lesion (RCSL) comprises the biochemical and biomechanical changes that take place during red blood cell (RBC) storage, reducing the survival and function of these cells. Contaminating white blood cells have been major contributors to the RCSL. Markers of RCSL, such as CD47 and phosphatidylserine (PS), on RBC are attracting more attention. The aim of this study was to elucidate the effects of storage time and buffy-coat removal on CD47 and PS expression on RBC. Potassium and free haemoglobin levels in the supernatant plasma were also assessed. METHODS Forty-three red cell concentrates were divided into two groups [Group 1: packed red cells (n=22); Group 2: red cell units from which the buffy-coat had been removed (n=21)] and samples were collected on days 1, 14 and 28. Flow cytometry was used to monitor changes of CD47 and PS expression on RBC over times. Supernatant potassium was measured and percent of haemolysis calculated. RESULTS A significant, progressive decrease in RBC CD47 expression during storage was observed in both groups. The decrease in RBC CD47 expression was significantly less in the buffy-coat-removed group of units than in the other group. The percentage of annexin V-positive cells increased significantly in both groups. Buffy-coat depleted components showed less expression of PS only in the early samples. There were significant, progressive increases in percentage of haemolysis and supernatant potassium during storage in both groups. CONCLUSIONS RBC stored for more than 14 days exhibited reduced CD47 and increased PS. Buffy coat removal reduced the loss of CD47, but had no impact on plasma haemoglobin, potassium or RBC PS exposure.

UI MeSH Term Description Entries
D010718 Phosphatidylserines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a SERINE moiety. Serine Phosphoglycerides,Phosphatidyl Serine,Phosphatidyl Serines,Phosphatidylserine,Phosphoglycerides, Serine,Serine, Phosphatidyl,Serines, Phosphatidyl
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D047589 Leukocyte Reduction Procedures The removal of LEUKOCYTES from BLOOD to reduce BLOOD TRANSFUSION reactions and lower the chance of transmitting VIRUSES. This may be performed by FILTRATION or by CYTAPHERESIS. Leukocyte Depletion Procedures,Leukocyte Reduction Filtration,Leukocyte Removal Procedures,Depletion Procedure, Leukocyte,Depletion Procedures, Leukocyte,Filtration, Leukocyte Reduction,Filtrations, Leukocyte Reduction,Leukocyte Depletion Procedure,Leukocyte Reduction Filtrations,Leukocyte Reduction Procedure,Leukocyte Removal Procedure,Procedure, Leukocyte Depletion,Procedure, Leukocyte Reduction,Procedure, Leukocyte Removal,Procedures, Leukocyte Depletion,Procedures, Leukocyte Reduction,Procedures, Leukocyte Removal,Reduction Filtration, Leukocyte,Reduction Filtrations, Leukocyte,Reduction Procedure, Leukocyte,Reduction Procedures, Leukocyte,Removal Procedure, Leukocyte,Removal Procedures, Leukocyte
D051928 CD47 Antigen A ubiquitously expressed membrane glycoprotein. It interacts with a variety of INTEGRINS and mediates responses to EXTRACELLULAR MATRIX PROTEINS. Antigens, CD47,CD47 Antigens,IAP-50 Antigen,Integrin-Associated Protein p50,Thrombospondin-1 Receptor CD47,Antigen, CD47,Antigen, IAP-50,CD47, Thrombospondin-1 Receptor,IAP 50 Antigen,Integrin Associated Protein p50
D058621 Blood Buffy Coat The fraction of a blood sample, following CENTRIFUGATION, that is distinguished as a thin light-colored layer between the RED BLOOD CELLS, underneath it, and the PLASMA, above it. It is composed mostly of WHITE BLOOD CELLS and PLATELETS. Buffy Coat, Blood,Blood Buffy Coats,Buffy Coats, Blood

Related Publications

Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
November 1994, Lancet (London, England),
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
November 1994, Lancet (London, England),
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
November 1994, Lancet (London, England),
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
April 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
March 2021, Surgery,
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
January 1991, Transfusion,
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
May 1964, American journal of veterinary research,
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
August 2006, Transfusion medicine (Oxford, England),
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
August 1994, Lancet (London, England),
Noha Kamel, and Fekry Goubran, and Neven Ramsis, and Amal Sayed Ahmed
September 1996, Lancet (London, England),
Copied contents to your clipboard!